NCT05526924 2026-03-04
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
University of Chicago
Phase 1 Recruiting
Clinical Trials
11 trialsNCT05417386 2025-11-18
FOLFIRINOX + NIS793 in Pancreatic Cancer
Massachusetts General Hospital
Phase 1 Terminated
NCT06191133 2025-10-02
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
Case Comprehensive Cancer Center
Phase 1 Recruiting
NCT06719362 2025-07-10
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
Providence Health & Services
Phase 1 Recruiting
NCT06300489 2024-03-08
Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital
Phase 1 Recruiting
NCT04393506 2023-11-22
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 1 Completed
NCT04473716 2023-11-22
Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients
Shanghai Jiao Tong University School of Medicine
Phase 1 Completed
NCT04522050 2023-07-12
Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 1 Unknown
NCT01118676 2022-05-24
Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Institut Claudius Regaud
Phase 1 Completed
NCT04882033 2021-05-11
Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Unknown
NCT02277158 2014-12-02
Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 1 Unknown